1. Home
  2. NABL vs AURA Comparison

NABL vs AURA Comparison

Compare NABL & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo N-able Inc.

NABL

N-able Inc.

HOLD

Current Price

$4.51

Market Cap

825.1M

Sector

Technology

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.04

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NABL
AURA
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
825.1M
713.4M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
NABL
AURA
Price
$4.51
$7.04
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$8.31
$20.00
AVG Volume (30 Days)
1.8M
549.7K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$511,430,000.00
N/A
Revenue This Year
$11.04
N/A
Revenue Next Year
$8.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.71
N/A
52 Week Low
$2.92
$4.73
52 Week High
$9.04
$9.54

Technical Indicators

Market Signals
Indicator
NABL
AURA
Relative Strength Index (RSI) 55.40 48.64
Support Level $4.15 $6.61
Resistance Level $5.06 $7.04
Average True Range (ATR) 0.32 0.31
MACD -0.04 0.00
Stochastic Oscillator 53.84 51.32

Price Performance

Historical Comparison
NABL
AURA

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. The company also has a presence in the United Kingdom and all other International regions.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: